Intellia Therapeutics doses first patient in MAGNITUDE-2 phase 3 study of nexiguran ziclumeran: Cambridge, Massachusetts Saturday, April 5, 2025, 18:00 Hrs [IST] Intellia Therapeu ...

Brisbane, California Saturday, April 5, 2025, 15:00 Hrs [IST] ...

Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee: Brisbane, California Saturday, April 5, 2 ...

EU approves AstraZeneca’s Imfinzi-in combo with chemotherapy to treat patients with resectable non-small cell lung cancer ...

US FDA approves Amgen’s Uplizna to treat IgG4-related disease: Thousand Oaks, California Saturday, April 5, 2025, 11:00 Hrs [IST] Amgen announced that the US Food and Drug Admin ...

The Clinical Trials Information System (CTIS) has been designated as a primary registry by the World Health Organisation (WHO) within the International Clinical Trials Registry Platform (ICTRP).

NIH-supported trial shows AI screening for opioid use disorder associated with fewer hospital readmissions: Bethesda, Maryland Saturday, April 5, 2025, 12:00 Hrs [IST] An artifici ...

Kapadia Hospital joins India’s first AI surgery revolution with MISSO, hailed by PM Modi: Our Bureau, Mumbai Friday, April 4, ...

Biologit boosts patient safety with automated local literature monitoring solution for non-indexed sources: Dublin, Ireland Friday, April 4, 2025, 18:00 Hrs [IST] Biologit, a spec ...

Helsinn Group submits new innovative formulation of Akynzeo to European Medicines Agency: Lugano, Switzerland Friday, April 4, 2025, 17:00 Hrs [IST] Helsinn Group, a global pharma ...

Abbott Park, Illinois Friday, April 4, 2025, 15:00 Hrs [IST] ...

Sova Health launches advanced microbiome tests & evidence-based precision supplements: Our Bureau, Bengaluru Friday, April 4, 2025, 16:50 Hrs [IST] Sova Health, India’s first fu ...